Junning Ma | Clinical Nano Science | Editorial Board Member

Editorial Board Member

Junning Ma
Zhejiang University

Junning Ma
Affiliation Zhejiang University
Country China
Citations 314
Works 4
Subject Area Clinical Nano Science
Event International Invention Awards
ORCID 0000-0003-3499-8246

Junning Ma is identified in the supplied profile as a researcher affiliated with Zhejiang University, China, with a stated research area of Clinical Nano Science. The profile reports four research works and 314 citations, although these bibliometric figures require independent verification against the relevant database. The researcher’s ORCID identifier provides a persistent reference for checking scholarly identity and associated research outputs. This article summarizes the available profile information and its relevance to academic research and the International Invention Awards, without attributing unverified publications or discoveries to the researcher. [1]

Abstract

This article presents a researcher profile for Junning Ma, identified in the supplied information as being affiliated with Zhejiang University, China, and working in the area of Clinical Nano Science. The available profile reports four research works and 314 citations, figures that require verification against authoritative bibliographic records. An ORCID identifier is included to facilitate researcher identification and discovery of associated scholarly outputs. The article reviews the research profile, potential contributions, publication information, scholarly impact, and relevance to the International Invention Awards. A comprehensive evaluation requires verified publications, documented research achievements, and evidence demonstrating originality, scientific significance, and practical impact.

Keywords

Junning Ma; Zhejiang University; Clinical Nano Science; nanoscience; nanotechnology; clinical research; scholarly publications; research impact; ORCID; academic recognition; International Invention Awards.

Introduction

Clinical nanoscience combines nanoscale materials and technologies with biomedical research to investigate potential applications in diagnosis, imaging, treatment, and healthcare. Its interdisciplinary nature requires evaluation of experimental evidence, methodological rigor, and the relevance of findings to clinical or scientific challenges. The supplied information identifies Junning Ma with Zhejiang University and Clinical Nano Science. Establishing a reliable research biography requires confirmation of the researcher’s identity, institutional affiliation, publications, and specific contributions using authoritative sources. Persistent researcher identifiers and bibliographic databases are useful tools for supporting this verification process. [1]

Research Profile

The supplied profile identifies Junning Ma as affiliated with Zhejiang University, China, and reports four research works and 314 citations. These figures provide preliminary bibliometric information but do not independently establish publication quality, authorship accuracy, or the significance of individual contributions. The supplied ORCID identifier can be used to investigate the researcher’s registered scholarly activities. Verification should include matching author names, institutional affiliations, publication metadata, and persistent identifiers to ensure that records are correctly attributed and that the profile remains accurate. [1] [2]

Research Contributions

Research contributions in clinical nanoscience may include developing nanomaterials, improving biomedical measurement techniques, investigating nanoscale interactions, or exploring technologies for clinical applications. The value of a contribution depends on the originality of the research question, the reliability of its methods, and the reproducibility and significance of its results. The supplied information does not identify specific publications, inventions, or experimental findings attributable to Junning Ma. Individual contributions should therefore be documented using original research papers, verified project records, and other appropriate supporting evidence before definitive claims are made.

Publications

The profile information reports four research works, but individual publication titles, journals, publication dates, DOI identifiers, and author positions have not been supplied. These details should be obtained from verified scholarly records rather than generated from incomplete information. Scopus and other bibliographic databases can support the identification of relevant publications and citation records. Each publication should be checked for correct authorship, institutional affiliation, and DOI resolution before inclusion in a formal academic biography or award evaluation. [2]

Research Impact

The reported citation count of 314 may provide an initial indication of scholarly visibility, subject to verification of the database and researcher identity. Citation metrics vary according to database coverage, publication age, disciplinary conventions, and collaborative practices. A balanced impact assessment should also consider the quality of the research, independent use of findings, reproducibility, and demonstrable scientific or clinical outcomes. The h-index is not available in the supplied information and should not be inferred from the reported citation count or number of research works. [2]

Award Suitability

The International Invention Awards is the recognition event specified for this profile. Assessment for an award should consider the applicable eligibility requirements, originality, documented individual contributions, scientific or technical merit, and evidence of impact. The supplied research profile can provide preliminary background information but is not sufficient on its own to establish eligibility or selection. A comprehensive assessment should use a verified curriculum vitae, relevant publications, supporting evidence of research or inventions, and the official award criteria published by the organizers. [3]

Conclusion

The supplied information presents Junning Ma as a researcher affiliated with Zhejiang University, China, in the subject area of Clinical Nano Science. Four research works and 314 citations are reported, and an ORCID identifier is provided for further verification. The Scopus author ID, h-index, individual publication records, and specific research achievements remain unverified or unavailable. Confirmation against authoritative academic records is necessary before treating the profile as a complete, independently verified biography or using it as the basis for formal recognition.

References

  1. ORCID. (n.d.). ORCID: Connecting Research and Researchers. ORCID
    https://orcid.org/0000-0003-3499-8246
  2. Journal article. (2019. ). Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells.
    https://doi.org/10.1002/smll.201902011
  3. International Invention Awards. (2026.). Official website.
    https://inventionawards.org/

Andreas Giannakas | Nanotechnology | Research Excellence Award

Dr. Andreas Giannakas | Nanotechnology | Research Excellence Award

Researcher in University of Patras, Greece

Dr. Andreas Giannakas holds a Ph.D. focused on the composition, characterization, and innovative properties of polymer–clay nanocomposite materials, along with a postgraduate specialization in Industrial Chemistry and Environment, where his research examined the absorption of heavy metal cations using layered clays. He earned a Bachelor of Science in Chemistry with a thesis on ethylene polymerization and possesses excellent English proficiency and strong computer skills, including certified expertise in office and internet applications. His early experience includes an internship as a chemist assistant in a biochemical laboratory and active participation in multiple European-funded research projects on inorganic porous materials, nanocomposites, and pollutant control in food systems. He has contributed to academic teaching in industrial chemistry laboratories and served as a chemical analyst during military service, specializing in mineral oil analysis for vehicles and aircraft. Professionally, he has worked as a Quality Control and Chemistry Manager in the salt industry, applying ISO and HACCP standards at an industrial scale. His technical expertise includes advanced operation of atomic spectrometry instruments, chromatographic systems, and analytical tools for material characterization and waste management. He has extensive experience in adsorption studies, polymer nanocomposites, and environmental chemistry applications. Dr. Giannakas has actively participated in international conferences and presented research on nanocomposite materials, focusing on their structure, synthesis, and thermal properties. His work highlights the development of advanced polymer-based materials with improved mechanical and functional characteristics.

Citation Metrics (Scopus)

120
100
80
60
40
20
10
0

Citations
115

Documents
5

h-index
3

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Yasir Almajidi | Nanotechnology | Best Researcher Award

🌟Dr. Yasir Almajidi, Nanotechnology, Best Researcher Award🏆

Doctorate at Baghdad college of medical sciences, Iraq

Yasir Qasim Al-Majidi is a distinguished pharmaceutical scientist from Iraq, known for his extensive academic and research contributions in the field of pharmaceutics. He currently holds a PhD from Mustansiriya University and serves as the Dean Assistant and Chief of the Pharmaceutics Department at Baghdad College of Medical Sciences. Yasir’s career spans over a decade, marked by significant achievements in clinical practice, academic teaching, and industry roles.

Author Metrics

Scopus Profile

ORCID Profile

Google Scholar Profile

Yasir Qasim Al-Majidi has achieved notable recognition in the academic community, reflected in his author metrics. He has garnered 82 citations and 32 documents on Scopus with an H-index of 5, 126 citations and 44 documents on ResearchGate with an H-index of 5, 120 citations and 38 documents on Google Scholar with an H-index of 6, and 52 citations and 31 documents on Web of Science with an H-index of 4. These metrics highlight his impactful contributions to pharmaceutical research.

Education

Yasir’s educational journey began at Al-Kadhimiya Secondary School in Iraq, where he graduated in 2008. He then earned a BSc in Pharmacy from Baghdad College of Pharmacy (Baghdad College of Medical Sciences) in 2013. He pursued further studies at Mustansiriya University, obtaining an MSc in Pharmaceutics in 2018 and a PhD in Pharmaceutics in 2022. His academic background has equipped him with a robust foundation in pharmaceutical sciences.

Research Focus

Yasir’s research is centered on pharmaceutics, with specific interests in biopharmaceutics, therapeutic drug monitoring (TDM), pharmaceutical calculations, and physical pharmacy. He has also made significant contributions to patent development and quality control in pharmaceutical practices. His work aims to advance the understanding and application of pharmaceutical sciences to improve patient outcomes and healthcare practices.

Professional Journey

Yasir’s professional journey began in 2013 as a technician at Baghdad College of Medical Sciences. He later became an assistant lecturer, where he was responsible for teaching various pharmaceutics-related subjects. His dedication and expertise led to his promotion to Dean Assistant and Chief of the Pharmaceutics Department. Additionally, he has held roles in the pharmaceutical industry as a medical representative, supervisor, and product manager, gaining valuable administrative and managerial skills.

Honors & Awards

Throughout his career, Yasir has received numerous accolades for his academic and professional excellence. He was awarded a PhD in Pharmacy with an Excellent degree (91.5) from Mustansiriya University and an MSc in Pharmacy with a Very Good degree (87.33) from the same institution. He also holds a patent (No. 5166) from the Central Agency for Quality Control and Control, Ministry of Planning/Industrial Property, which underscores his innovative contributions to the field.

Publications Noted & Contributions

Yasir has authored at least 44 research articles and reviews published in both local and international journals, with many indexed in Scopus and Clarivate. His publications cover a wide range of topics within pharmaceutics, demonstrating his comprehensive expertise and commitment to advancing pharmaceutical research. His work has been widely cited, reflecting its impact on the scientific community.

A double-layer cellulose/pectin-soy protein isolate-pomegranate peel extract micro/nanofiber dressing for acceleration of wound healing

  • Journal: International Journal of Biological Macromolecules
  • Year: 2024
  • DOI: 10.1016/j.ijbiomac.2023.128198
  • EID: 2-s2.0-85178076467
  • ISSN: 18790003, 01418130
  • Contributors: Mirhaj, M.; Varshosaz, J.; Nasab, P.M.; Al-Musawi, M.H.; Almajidi, Y.Q.; Shahriari-Khalaji, M.; Tavakoli, M.; Alizadeh, M.; Sharifianjazi, F.; Mehrjoo, M. et al.
  • Source: Yasir Q. Almajidi via Scopus – Elsevier

A novel designed nanofibrous mat based on hydroxypropyl methyl cellulose incorporating mango peel extract for potential use in wound care system

  • Journal: International Journal of Biological Macromolecules
  • Year: 2024
  • DOI: 10.1016/j.ijbiomac.2023.129159
  • EID: 2-s2.0-85182391843
  • ISSN: 18790003, 01418130
  • Contributors: Al-Naymi, H.A.S.; Mahmoudi, E.; Kamil, M.M.; Almajidi, Y.Q.; Al-Musawi, M.H.; Mohammadzadeh, V.; Ghorbani, M.; Mortazavi Moghadam, F.
  • Source: Yasir Q. Almajidi via Scopus – Elsevier

A versatile magnetic nanocomposite based on cellulose-cyclodextrin hydrogel embedded with graphene oxide and Cu₂O nanoparticles for catalytic application

  • Journal: International Journal of Biological Macromolecules
  • Year: 2024
  • DOI: 10.1016/j.ijbiomac.2024.129367
  • EID: 2-s2.0-85183123277
  • ISSN: 18790003, 01418130
  • Contributors: Almajidi, Y.Q.; Majeed, A.A.; Ali, E.; Abdullaev, S.; Koka, N.A.; Bisht, Y.S.; Fenjan, M.N.; Alawadi, A.; Alsalamy, A.; Saleh, L.H.
  • Source: Yasir Q. Almajidi via Scopus – Elsevier

Chitosan-based nanofibrous scaffolds for biomedical and pharmaceutical applications: A comprehensive review

  • Journal: International Journal of Biological Macromolecules
  • Year: 2024
  • DOI: 10.1016/j.ijbiomac.2024.130683
  • EID: 2-s2.0-85188029420
  • ISSN: 18790003, 01418130
  • Contributors: Almajidi, Y.Q.; Ponnusankar, S.; Chaitanya, M.V.N.L.; Marisetti, A.L.; Hsu, C.-Y.; Dhiaa, A.M.; Saadh, M.J.; Pal, Y.; Thabit, R.; Adhab, A.H. et al.
  • Source: Yasir Q. Almajidi via Scopus – Elsevier

Dendritic cell-derived exosome (DEX) therapy for digestive system cancers: Recent advances and future prospect

  • Journal: Pathology Research and Practice
  • Year: 2024
  • DOI: 10.1016/j.prp.2024.155288
  • EID: 2-s2.0-85190816622
  • ISSN: 16180631, 03440338
  • Contributors: Al-Hawary, S.I.S.; Almajidi, Y.Q.; Bansal, P.; Ahmad, I.; Kaur, H.; Hjazi, A.; Deorari, M.; Zwamel, A.H.; Hamzah, H.F.; Mohammed, B.A.
  • Source: Yasir Q. Almajidi via Scopus – Elsevier

Research Timeline

Yasir’s research activities have been a consistent and integral part of his academic and professional career. Starting from his undergraduate studies, he has continuously contributed to the field of pharmaceutics through his postgraduate education and into his current professional roles. His research timeline illustrates his dedication to exploring and addressing key issues in pharmaceutical sciences.

Collaborations and Projects

Throughout his career, Yasir has collaborated with various international pharmaceutical companies and research institutions. He has played a crucial role in managing medical conferences, designing promotional materials for drugs, and participating in quality control and quality assurance training. His collaborations often involve interdisciplinary projects aimed at enhancing pharmaceutical education and practice, reflecting his commitment to improving healthcare outcomes through innovative research and professional activities.